McGill Alert / Alerte de McGill

Updated: Fri, 07/12/2024 - 12:16

McGill Alert. The downtown campus will remain partially closed through the evening of Monday, July 15. See the Campus Safety site for details.

Alerte de McGill. Le campus du centre-ville restera partiellement fermé jusqu’au lundi 15 juillet, en soirée. Complément d’information : Direction de la protection et de la prévention

Marie Hudson

Academic title(s): 

Associate Professor - Department of Medicine, Division of Experimental Medicine

Contact Information
Address: 

Lady Davis Institute for Medical Research
Jewish General Hospital
3755 Côte Ste-Catherine Road,
Montreal, Qc, H3T 1E2
Phone: (514) 340-8222 ext. 23476

Email address: 
marie.hudson [at] mcgill.ca
Group: 
Immunotherapy
Current research: 

My research program has two axes: (1) systemic autoimmune rheumatic diseases, and (2) immune-related adverse events (irAE) secondary to cancer immunotherapies.

1) Systemic autoimmune rheumatic diseases

I am particularly interested in systemic sclerosis and autoimmune myositis. I have recently developed an interest in cellular therapies for autoimmune diseases, including autologous hematopoietic stem cell transplant and mesenchymal stromal cells. I am also interested in translational projects in scleromyositis and epigenetic signatures of disease.

2) Immune-related adverse events (irAE) secondary to cancer immunotherapies

Most recently, I have developed an interest in immune-related adverse events (irAE) secondary to cancer immunotherapies as a “human” model for classical autoimmune diseases. Specifically, we are trying to identify predictive biomarkers, mechanisms of irAE and mitigation strategies in order to optimize the use of immunotherapies and improve outcomes of cancer patients.

Back to top